Within MVPs, clinicians can focus on a specialty, such as rheumatology, or a specific condition, such as rheumatoid arthritis. The reporting categories under MVPs will be the same as they are under MIPS. However, the number of measures selected in each category will change.
- Quality: Clinicians should report four measures, with at least one outcome or high-quality measure.
- Improvement activities: Clinicians should report two medium-weighted or one high-weighted activity.
- Promoting interoperability: Clinicians should report all measures.
- Cost: This category requires no actual reporting; the CMS will calculate cost based on a variety of claims.
A new layer added to the measures is population health, which involves administration claims measures and no specific data submission, Dr. Harvey said. For now, the two population health measures from which to choose are 1) hospitalwide, 30-day, all-cause, unplanned readmission rate for the MIPS groups; or 2) clinician and clinician group risk-standardized hospital admission rates for patients with multiple chronic conditions. MVP participants will select one population health measure to be added in the quality score.
Dr. Huston also shared how MIPS category weighting will change in 2022. Quality will drop from 40% to 30%; cost will rise from 20% to 30%. Promoting interoperability and improvement activities will remain the same at 25% and 15%, respectively. The performance threshold will increase from 60 to 75 points in 2022.
Readying for Success
Dr. Harvey shared a few questions that rheumatologists can ask themselves to measure their potential success under the proposed MVP:
- Are you tracking performance on the quality measures included in the MVP?
- How well are you performing on those measures?
- Are the improvement activities included in the MVP meaningful and reasonably implemented in your practice?
- Are you an early adapter, or do you prefer to wait for later versions? As with any new experience, there will be bugs to get fixed after the initial launch, Dr. Harvey said.
- Do you have the time and/or ability to report for both MVP and MIPS? From any reporting type, the CMS will use the highest reporting score.
These questions can help show where you may need to make some changes and improvements before starting MVPs, Dr. Harvey said.
Both Dr. Huston and Dr. Harvey emphasized the value of participating in the ACR’s RISE Registry to easily report MVP measures. Rheumatologists can email [email protected] to ask questions, give feedback about MVPs or learn more about RISE participation. There is no extra cost for ACR members to use the RISE registry.
